nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CES1—Capecitabine—colon cancer	0.433	0.506	CbGbCtD
Rufinamide—CES1—Irinotecan—colon cancer	0.268	0.313	CbGbCtD
Rufinamide—ALB—Irinotecan—colon cancer	0.0504	0.0589	CbGbCtD
Rufinamide—ALB—Fluorouracil—colon cancer	0.0484	0.0565	CbGbCtD
Rufinamide—ALB—Methotrexate—colon cancer	0.0267	0.0311	CbGbCtD
Rufinamide—CYP3A4—Irinotecan—colon cancer	0.0158	0.0184	CbGbCtD
Rufinamide—CYP3A4—Vincristine—colon cancer	0.0138	0.0161	CbGbCtD
Rufinamide—Balance disorder—Fluorouracil—colon cancer	0.00251	0.0226	CcSEcCtD
Rufinamide—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00233	0.021	CcSEcCtD
Rufinamide—Nystagmus—Vincristine—colon cancer	0.00206	0.0186	CcSEcCtD
Rufinamide—Nystagmus—Fluorouracil—colon cancer	0.00192	0.0173	CcSEcCtD
Rufinamide—Balance disorder—Capecitabine—colon cancer	0.00175	0.0158	CcSEcCtD
Rufinamide—CES1—gall bladder—colon cancer	0.00168	0.104	CbGeAlD
Rufinamide—Gait disturbance—Vincristine—colon cancer	0.00151	0.0136	CcSEcCtD
Rufinamide—Gait disturbance—Irinotecan—colon cancer	0.00147	0.0132	CcSEcCtD
Rufinamide—Urine output increased—Vincristine—colon cancer	0.00133	0.012	CcSEcCtD
Rufinamide—SCN11A—digestive system—colon cancer	0.00125	0.0772	CbGeAlD
Rufinamide—Polyuria—Vincristine—colon cancer	0.00121	0.011	CcSEcCtD
Rufinamide—ALB—gall bladder—colon cancer	0.00117	0.0724	CbGeAlD
Rufinamide—Contusion—Capecitabine—colon cancer	0.0011	0.0099	CcSEcCtD
Rufinamide—Nocturia—Capecitabine—colon cancer	0.00103	0.00931	CcSEcCtD
Rufinamide—Ataxia—Vincristine—colon cancer	0.001	0.00904	CcSEcCtD
Rufinamide—Gait disturbance—Capecitabine—colon cancer	0.000981	0.00885	CcSEcCtD
Rufinamide—Coordination abnormal—Capecitabine—colon cancer	0.000975	0.0088	CcSEcCtD
Rufinamide—Ataxia—Fluorouracil—colon cancer	0.000935	0.00844	CcSEcCtD
Rufinamide—Urinary incontinence—Capecitabine—colon cancer	0.000925	0.00834	CcSEcCtD
Rufinamide—SCN4A—renal system—colon cancer	0.000903	0.0559	CbGeAlD
Rufinamide—Nasopharyngitis—Fluorouracil—colon cancer	0.000889	0.00802	CcSEcCtD
Rufinamide—Urine output increased—Capecitabine—colon cancer	0.000866	0.00781	CcSEcCtD
Rufinamide—Neutropenia—Vincristine—colon cancer	0.000862	0.00777	CcSEcCtD
Rufinamide—Dysuria—Vincristine—colon cancer	0.000862	0.00777	CcSEcCtD
Rufinamide—Neutropenia—Irinotecan—colon cancer	0.000839	0.00757	CcSEcCtD
Rufinamide—Weight decreased—Vincristine—colon cancer	0.000834	0.00752	CcSEcCtD
Rufinamide—Pneumonia—Vincristine—colon cancer	0.000827	0.00746	CcSEcCtD
Rufinamide—Weight decreased—Irinotecan—colon cancer	0.000812	0.00733	CcSEcCtD
Rufinamide—Pneumonia—Irinotecan—colon cancer	0.000805	0.00726	CcSEcCtD
Rufinamide—Polyuria—Capecitabine—colon cancer	0.000792	0.00714	CcSEcCtD
Rufinamide—SCN7A—liver—colon cancer	0.00079	0.0489	CbGeAlD
Rufinamide—Bone disorder—Methotrexate—colon cancer	0.000789	0.00712	CcSEcCtD
Rufinamide—Pneumonia—Fluorouracil—colon cancer	0.000771	0.00695	CcSEcCtD
Rufinamide—Infestation—Fluorouracil—colon cancer	0.000767	0.00691	CcSEcCtD
Rufinamide—Infestation NOS—Fluorouracil—colon cancer	0.000767	0.00691	CcSEcCtD
Rufinamide—Increased appetite—Capecitabine—colon cancer	0.00074	0.00667	CcSEcCtD
Rufinamide—Urinary tract disorder—Vincristine—colon cancer	0.000729	0.00657	CcSEcCtD
Rufinamide—Urethral disorder—Vincristine—colon cancer	0.000723	0.00652	CcSEcCtD
Rufinamide—Epistaxis—Fluorouracil—colon cancer	0.000723	0.00652	CcSEcCtD
Rufinamide—Rhinitis—Irinotecan—colon cancer	0.00072	0.0065	CcSEcCtD
Rufinamide—Sinusitis—Fluorouracil—colon cancer	0.000719	0.00649	CcSEcCtD
Rufinamide—SCN3A—renal system—colon cancer	0.000702	0.0435	CbGeAlD
Rufinamide—Diplopia—Capecitabine—colon cancer	0.000695	0.00627	CcSEcCtD
Rufinamide—Rhinitis—Fluorouracil—colon cancer	0.00069	0.00622	CcSEcCtD
Rufinamide—Cardiac disorder—Vincristine—colon cancer	0.000685	0.00618	CcSEcCtD
Rufinamide—CES1—lymphoid tissue—colon cancer	0.00067	0.0415	CbGeAlD
Rufinamide—Cardiac disorder—Irinotecan—colon cancer	0.000667	0.00601	CcSEcCtD
Rufinamide—Mediastinal disorder—Vincristine—colon cancer	0.000665	0.006	CcSEcCtD
Rufinamide—CES1—digestive system—colon cancer	0.000661	0.041	CbGeAlD
Rufinamide—Ataxia—Capecitabine—colon cancer	0.000654	0.0059	CcSEcCtD
Rufinamide—Immune system disorder—Irinotecan—colon cancer	0.000649	0.00585	CcSEcCtD
Rufinamide—Mediastinal disorder—Irinotecan—colon cancer	0.000648	0.00584	CcSEcCtD
Rufinamide—Mental disorder—Vincristine—colon cancer	0.000646	0.00583	CcSEcCtD
Rufinamide—Urine output increased—Methotrexate—colon cancer	0.000645	0.00581	CcSEcCtD
Rufinamide—SCN10A—lymphoid tissue—colon cancer	0.00064	0.0396	CbGeAlD
Rufinamide—Abdominal pain upper—Capecitabine—colon cancer	0.000635	0.00573	CcSEcCtD
Rufinamide—Breast disorder—Capecitabine—colon cancer	0.000628	0.00567	CcSEcCtD
Rufinamide—Nasopharyngitis—Capecitabine—colon cancer	0.000622	0.00561	CcSEcCtD
Rufinamide—Back pain—Vincristine—colon cancer	0.000621	0.0056	CcSEcCtD
Rufinamide—Lymphadenopathy—Methotrexate—colon cancer	0.000606	0.00547	CcSEcCtD
Rufinamide—SCN7A—lymph node—colon cancer	0.000605	0.0375	CbGeAlD
Rufinamide—Back pain—Irinotecan—colon cancer	0.000605	0.00546	CcSEcCtD
Rufinamide—Influenza—Capecitabine—colon cancer	0.000601	0.00542	CcSEcCtD
Rufinamide—Anaemia—Vincristine—colon cancer	0.000594	0.00535	CcSEcCtD
Rufinamide—Agitation—Vincristine—colon cancer	0.00059	0.00532	CcSEcCtD
Rufinamide—Polyuria—Methotrexate—colon cancer	0.000589	0.00532	CcSEcCtD
Rufinamide—SCN2A—vagina—colon cancer	0.000579	0.0359	CbGeAlD
Rufinamide—Anaemia—Irinotecan—colon cancer	0.000578	0.00521	CcSEcCtD
Rufinamide—Bronchitis—Capecitabine—colon cancer	0.000578	0.00521	CcSEcCtD
Rufinamide—Vertigo—Vincristine—colon cancer	0.000577	0.0052	CcSEcCtD
Rufinamide—Leukopenia—Vincristine—colon cancer	0.000575	0.00519	CcSEcCtD
Rufinamide—SCN5A—digestive system—colon cancer	0.000574	0.0356	CbGeAlD
Rufinamide—Vision blurred—Fluorouracil—colon cancer	0.000565	0.00509	CcSEcCtD
Rufinamide—Vertigo—Irinotecan—colon cancer	0.000562	0.00507	CcSEcCtD
Rufinamide—Dysuria—Capecitabine—colon cancer	0.000562	0.00507	CcSEcCtD
Rufinamide—Neutropenia—Capecitabine—colon cancer	0.000562	0.00507	CcSEcCtD
Rufinamide—Leukopenia—Irinotecan—colon cancer	0.00056	0.00505	CcSEcCtD
Rufinamide—Convulsion—Vincristine—colon cancer	0.000556	0.00502	CcSEcCtD
Rufinamide—Anaemia—Fluorouracil—colon cancer	0.000554	0.00499	CcSEcCtD
Rufinamide—Weight decreased—Capecitabine—colon cancer	0.000544	0.0049	CcSEcCtD
Rufinamide—Pneumonia—Capecitabine—colon cancer	0.000539	0.00486	CcSEcCtD
Rufinamide—Leukopenia—Fluorouracil—colon cancer	0.000536	0.00484	CcSEcCtD
Rufinamide—Infestation—Capecitabine—colon cancer	0.000536	0.00483	CcSEcCtD
Rufinamide—Infestation NOS—Capecitabine—colon cancer	0.000536	0.00483	CcSEcCtD
Rufinamide—SCN3A—bone marrow—colon cancer	0.000531	0.0329	CbGeAlD
Rufinamide—Infection—Vincristine—colon cancer	0.000521	0.0047	CcSEcCtD
Rufinamide—Convulsion—Fluorouracil—colon cancer	0.000519	0.00468	CcSEcCtD
Rufinamide—Nervous system disorder—Vincristine—colon cancer	0.000514	0.00464	CcSEcCtD
Rufinamide—Thrombocytopenia—Vincristine—colon cancer	0.000513	0.00463	CcSEcCtD
Rufinamide—Haematuria—Capecitabine—colon cancer	0.000511	0.00461	CcSEcCtD
Rufinamide—SCN3A—vagina—colon cancer	0.000509	0.0315	CbGeAlD
Rufinamide—SCN5A—vagina—colon cancer	0.000507	0.0314	CbGeAlD
Rufinamide—Infection—Irinotecan—colon cancer	0.000507	0.00457	CcSEcCtD
Rufinamide—Hepatobiliary disease—Capecitabine—colon cancer	0.000507	0.00457	CcSEcCtD
Rufinamide—Epistaxis—Capecitabine—colon cancer	0.000505	0.00456	CcSEcCtD
Rufinamide—Nervous system disorder—Irinotecan—colon cancer	0.000501	0.00452	CcSEcCtD
Rufinamide—Thrombocytopenia—Irinotecan—colon cancer	0.0005	0.00451	CcSEcCtD
Rufinamide—Anorexia—Vincristine—colon cancer	0.0005	0.00451	CcSEcCtD
Rufinamide—CES1—liver—colon cancer	0.000493	0.0305	CbGeAlD
Rufinamide—Anorexia—Irinotecan—colon cancer	0.000487	0.00439	CcSEcCtD
Rufinamide—Ataxia—Methotrexate—colon cancer	0.000487	0.00439	CcSEcCtD
Rufinamide—Infection—Fluorouracil—colon cancer	0.000486	0.00438	CcSEcCtD
Rufinamide—Rhinitis—Capecitabine—colon cancer	0.000482	0.00435	CcSEcCtD
Rufinamide—Nervous system disorder—Fluorouracil—colon cancer	0.000479	0.00432	CcSEcCtD
Rufinamide—Thrombocytopenia—Fluorouracil—colon cancer	0.000479	0.00432	CcSEcCtD
Rufinamide—Urinary tract disorder—Capecitabine—colon cancer	0.000475	0.00428	CcSEcCtD
Rufinamide—SCN9A—lymph node—colon cancer	0.000474	0.0294	CbGeAlD
Rufinamide—Insomnia—Vincristine—colon cancer	0.000474	0.00428	CcSEcCtD
Rufinamide—Urethral disorder—Capecitabine—colon cancer	0.000471	0.00425	CcSEcCtD
Rufinamide—Breast disorder—Methotrexate—colon cancer	0.000468	0.00422	CcSEcCtD
Rufinamide—Anorexia—Fluorouracil—colon cancer	0.000466	0.0042	CcSEcCtD
Rufinamide—Insomnia—Irinotecan—colon cancer	0.000462	0.00416	CcSEcCtD
Rufinamide—Decreased appetite—Vincristine—colon cancer	0.000456	0.00411	CcSEcCtD
Rufinamide—Somnolence—Irinotecan—colon cancer	0.000454	0.00409	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Vincristine—colon cancer	0.000453	0.00408	CcSEcCtD
Rufinamide—Fatigue—Vincristine—colon cancer	0.000452	0.00408	CcSEcCtD
Rufinamide—Eye disorder—Capecitabine—colon cancer	0.000449	0.00405	CcSEcCtD
Rufinamide—Dyspepsia—Irinotecan—colon cancer	0.000449	0.00405	CcSEcCtD
Rufinamide—Constipation—Vincristine—colon cancer	0.000448	0.00404	CcSEcCtD
Rufinamide—Cardiac disorder—Capecitabine—colon cancer	0.000446	0.00403	CcSEcCtD
Rufinamide—Decreased appetite—Irinotecan—colon cancer	0.000444	0.004	CcSEcCtD
Rufinamide—Insomnia—Fluorouracil—colon cancer	0.000442	0.00399	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000441	0.00397	CcSEcCtD
Rufinamide—Fatigue—Irinotecan—colon cancer	0.00044	0.00397	CcSEcCtD
Rufinamide—Constipation—Irinotecan—colon cancer	0.000437	0.00394	CcSEcCtD
Rufinamide—Somnolence—Fluorouracil—colon cancer	0.000435	0.00392	CcSEcCtD
Rufinamide—Immune system disorder—Capecitabine—colon cancer	0.000434	0.00392	CcSEcCtD
Rufinamide—Mediastinal disorder—Capecitabine—colon cancer	0.000433	0.00391	CcSEcCtD
Rufinamide—Dyspepsia—Fluorouracil—colon cancer	0.00043	0.00388	CcSEcCtD
Rufinamide—Decreased appetite—Fluorouracil—colon cancer	0.000425	0.00383	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000422	0.00381	CcSEcCtD
Rufinamide—Mental disorder—Capecitabine—colon cancer	0.000421	0.0038	CcSEcCtD
Rufinamide—Malnutrition—Capecitabine—colon cancer	0.000419	0.00378	CcSEcCtD
Rufinamide—Neutropenia—Methotrexate—colon cancer	0.000418	0.00377	CcSEcCtD
Rufinamide—Dysuria—Methotrexate—colon cancer	0.000418	0.00377	CcSEcCtD
Rufinamide—Back pain—Capecitabine—colon cancer	0.000405	0.00365	CcSEcCtD
Rufinamide—Pneumonia—Methotrexate—colon cancer	0.000401	0.00362	CcSEcCtD
Rufinamide—Infestation—Methotrexate—colon cancer	0.000399	0.0036	CcSEcCtD
Rufinamide—Infestation NOS—Methotrexate—colon cancer	0.000399	0.0036	CcSEcCtD
Rufinamide—Vision blurred—Capecitabine—colon cancer	0.000395	0.00356	CcSEcCtD
Rufinamide—Tremor—Capecitabine—colon cancer	0.000392	0.00354	CcSEcCtD
Rufinamide—Anaemia—Capecitabine—colon cancer	0.000387	0.00349	CcSEcCtD
Rufinamide—Hypersensitivity—Vincristine—colon cancer	0.000386	0.00348	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—colon cancer	0.00038	0.00343	CcSEcCtD
Rufinamide—CES1—lymph node—colon cancer	0.000378	0.0234	CbGeAlD
Rufinamide—Hepatobiliary disease—Methotrexate—colon cancer	0.000377	0.0034	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—colon cancer	0.000376	0.00339	CcSEcCtD
Rufinamide—Vertigo—Capecitabine—colon cancer	0.000376	0.00339	CcSEcCtD
Rufinamide—Hypersensitivity—Irinotecan—colon cancer	0.000376	0.00339	CcSEcCtD
Rufinamide—Asthenia—Vincristine—colon cancer	0.000376	0.00339	CcSEcCtD
Rufinamide—Leukopenia—Capecitabine—colon cancer	0.000375	0.00338	CcSEcCtD
Rufinamide—Asthenia—Irinotecan—colon cancer	0.000366	0.0033	CcSEcCtD
Rufinamide—SCN10A—lymph node—colon cancer	0.000361	0.0224	CbGeAlD
Rufinamide—Hypersensitivity—Fluorouracil—colon cancer	0.00036	0.00325	CcSEcCtD
Rufinamide—Diarrhoea—Vincristine—colon cancer	0.000359	0.00323	CcSEcCtD
Rufinamide—Anxiety—Capecitabine—colon cancer	0.000355	0.0032	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000354	0.00319	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—colon cancer	0.000354	0.00319	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—colon cancer	0.000351	0.00317	CcSEcCtD
Rufinamide—Diarrhoea—Irinotecan—colon cancer	0.000349	0.00315	CcSEcCtD
Rufinamide—Dizziness—Vincristine—colon cancer	0.000347	0.00313	CcSEcCtD
Rufinamide—Pruritus—Fluorouracil—colon cancer	0.000346	0.00312	CcSEcCtD
Rufinamide—ALB—liver—colon cancer	0.000343	0.0212	CbGeAlD
Rufinamide—Infection—Capecitabine—colon cancer	0.000339	0.00306	CcSEcCtD
Rufinamide—Dizziness—Irinotecan—colon cancer	0.000338	0.00304	CcSEcCtD
Rufinamide—Nervous system disorder—Capecitabine—colon cancer	0.000335	0.00302	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—colon cancer	0.000335	0.00302	CcSEcCtD
Rufinamide—Diarrhoea—Fluorouracil—colon cancer	0.000335	0.00302	CcSEcCtD
Rufinamide—Thrombocytopenia—Capecitabine—colon cancer	0.000335	0.00302	CcSEcCtD
Rufinamide—Vomiting—Vincristine—colon cancer	0.000333	0.00301	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—colon cancer	0.000332	0.003	CcSEcCtD
Rufinamide—Skin disorder—Capecitabine—colon cancer	0.000332	0.00299	CcSEcCtD
Rufinamide—CYP2E1—renal system—colon cancer	0.000332	0.0205	CbGeAlD
Rufinamide—Rash—Vincristine—colon cancer	0.00033	0.00298	CcSEcCtD
Rufinamide—Dermatitis—Vincristine—colon cancer	0.00033	0.00298	CcSEcCtD
Rufinamide—SCN3A—lymph node—colon cancer	0.000329	0.0204	CbGeAlD
Rufinamide—Headache—Vincristine—colon cancer	0.000328	0.00296	CcSEcCtD
Rufinamide—Anorexia—Capecitabine—colon cancer	0.000326	0.00294	CcSEcCtD
Rufinamide—Vomiting—Irinotecan—colon cancer	0.000325	0.00293	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—colon cancer	0.000323	0.00292	CcSEcCtD
Rufinamide—Dizziness—Fluorouracil—colon cancer	0.000323	0.00292	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—colon cancer	0.000323	0.00291	CcSEcCtD
Rufinamide—Rash—Irinotecan—colon cancer	0.000322	0.0029	CcSEcCtD
Rufinamide—Dermatitis—Irinotecan—colon cancer	0.000322	0.0029	CcSEcCtD
Rufinamide—Headache—Irinotecan—colon cancer	0.00032	0.00288	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—colon cancer	0.000314	0.00283	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—colon cancer	0.000312	0.00281	CcSEcCtD
Rufinamide—Nausea—Vincristine—colon cancer	0.000311	0.00281	CcSEcCtD
Rufinamide—Vomiting—Fluorouracil—colon cancer	0.000311	0.0028	CcSEcCtD
Rufinamide—Insomnia—Capecitabine—colon cancer	0.000309	0.00279	CcSEcCtD
Rufinamide—Rash—Fluorouracil—colon cancer	0.000308	0.00278	CcSEcCtD
Rufinamide—Dermatitis—Fluorouracil—colon cancer	0.000308	0.00278	CcSEcCtD
Rufinamide—Headache—Fluorouracil—colon cancer	0.000306	0.00276	CcSEcCtD
Rufinamide—Nausea—Irinotecan—colon cancer	0.000303	0.00273	CcSEcCtD
Rufinamide—Back pain—Methotrexate—colon cancer	0.000301	0.00272	CcSEcCtD
Rufinamide—Dyspepsia—Capecitabine—colon cancer	0.000301	0.00271	CcSEcCtD
Rufinamide—Decreased appetite—Capecitabine—colon cancer	0.000297	0.00268	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000295	0.00266	CcSEcCtD
Rufinamide—Fatigue—Capecitabine—colon cancer	0.000295	0.00266	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—colon cancer	0.000294	0.00265	CcSEcCtD
Rufinamide—Constipation—Capecitabine—colon cancer	0.000292	0.00264	CcSEcCtD
Rufinamide—Nausea—Fluorouracil—colon cancer	0.00029	0.00262	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—colon cancer	0.000288	0.0026	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—colon cancer	0.00028	0.00253	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—colon cancer	0.000279	0.00252	CcSEcCtD
Rufinamide—CYP2E1—lymphoid tissue—colon cancer	0.000275	0.0171	CbGeAlD
Rufinamide—CYP2E1—digestive system—colon cancer	0.000272	0.0169	CbGeAlD
Rufinamide—Convulsion—Methotrexate—colon cancer	0.00027	0.00244	CcSEcCtD
Rufinamide—CYP3A4—renal system—colon cancer	0.000267	0.0165	CbGeAlD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000263	0.00238	CcSEcCtD
Rufinamide—ALB—lymph node—colon cancer	0.000263	0.0163	CbGeAlD
Rufinamide—Infection—Methotrexate—colon cancer	0.000253	0.00228	CcSEcCtD
Rufinamide—Hypersensitivity—Capecitabine—colon cancer	0.000252	0.00227	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—colon cancer	0.000249	0.00225	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—colon cancer	0.000249	0.00225	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—colon cancer	0.000247	0.00223	CcSEcCtD
Rufinamide—Asthenia—Capecitabine—colon cancer	0.000245	0.00221	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—colon cancer	0.000242	0.00219	CcSEcCtD
Rufinamide—Pruritus—Capecitabine—colon cancer	0.000242	0.00218	CcSEcCtD
Rufinamide—Diarrhoea—Capecitabine—colon cancer	0.000234	0.00211	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—colon cancer	0.00023	0.00207	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—colon cancer	0.000226	0.00204	CcSEcCtD
Rufinamide—Dizziness—Capecitabine—colon cancer	0.000226	0.00204	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—colon cancer	0.000224	0.00202	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—colon cancer	0.000221	0.00199	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—colon cancer	0.00022	0.00198	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—colon cancer	0.000219	0.00198	CcSEcCtD
Rufinamide—CYP3A4—digestive system—colon cancer	0.000219	0.0136	CbGeAlD
Rufinamide—Vomiting—Capecitabine—colon cancer	0.000217	0.00196	CcSEcCtD
Rufinamide—Rash—Capecitabine—colon cancer	0.000215	0.00194	CcSEcCtD
Rufinamide—Dermatitis—Capecitabine—colon cancer	0.000215	0.00194	CcSEcCtD
Rufinamide—Headache—Capecitabine—colon cancer	0.000214	0.00193	CcSEcCtD
Rufinamide—Nausea—Capecitabine—colon cancer	0.000203	0.00183	CcSEcCtD
Rufinamide—CYP2E1—liver—colon cancer	0.000203	0.0126	CbGeAlD
Rufinamide—Hypersensitivity—Methotrexate—colon cancer	0.000187	0.00169	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—colon cancer	0.000182	0.00165	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—colon cancer	0.00018	0.00162	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—colon cancer	0.000174	0.00157	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—colon cancer	0.000168	0.00152	CcSEcCtD
Rufinamide—CYP3A4—liver—colon cancer	0.000163	0.0101	CbGeAlD
Rufinamide—Vomiting—Methotrexate—colon cancer	0.000162	0.00146	CcSEcCtD
Rufinamide—Rash—Methotrexate—colon cancer	0.00016	0.00145	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—colon cancer	0.00016	0.00145	CcSEcCtD
Rufinamide—Headache—Methotrexate—colon cancer	0.000159	0.00144	CcSEcCtD
Rufinamide—Nausea—Methotrexate—colon cancer	0.000151	0.00136	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—NRAS—colon cancer	4.99e-05	0.00294	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CASP3—colon cancer	4.93e-05	0.0029	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—KRAS—colon cancer	4.82e-05	0.00284	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—colon cancer	4.75e-05	0.0028	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—SRC—colon cancer	4.75e-05	0.0028	CbGpPWpGaD
Rufinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.65e-05	0.00274	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—VEGFA—colon cancer	4.63e-05	0.00272	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CTNNB1—colon cancer	4.6e-05	0.00271	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—NRAS—colon cancer	4.57e-05	0.00269	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—EGFR—colon cancer	4.55e-05	0.00268	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—EP300—colon cancer	4.42e-05	0.0026	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—PPARG—colon cancer	4.31e-05	0.00254	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—KRAS—colon cancer	4.3e-05	0.00253	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EP300—colon cancer	4.27e-05	0.00252	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CA7—colon cancer	4.21e-05	0.00248	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.18e-05	0.00246	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—EGFR—colon cancer	4.16e-05	0.00245	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—SRC—colon cancer	4.16e-05	0.00245	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—PPARG—colon cancer	4.12e-05	0.00243	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—HRAS—colon cancer	4.1e-05	0.00241	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CTNNB1—colon cancer	4.1e-05	0.00241	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VEGFA—colon cancer	4.05e-05	0.00238	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—NRAS—colon cancer	4e-05	0.00235	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—PPARG—colon cancer	3.96e-05	0.00233	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—PPARG—colon cancer	3.96e-05	0.00233	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—KRAS—colon cancer	3.93e-05	0.00231	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—SRC—colon cancer	3.84e-05	0.00226	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—PPARG—colon cancer	3.82e-05	0.00225	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—PPARG—colon cancer	3.82e-05	0.00225	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EP300—colon cancer	3.81e-05	0.00224	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CTNNB1—colon cancer	3.75e-05	0.00221	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VEGFA—colon cancer	3.74e-05	0.0022	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TGFB1—colon cancer	3.72e-05	0.00219	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—SRC—colon cancer	3.71e-05	0.00218	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—NRAS—colon cancer	3.69e-05	0.00217	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—SRC—colon cancer	3.67e-05	0.00216	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—HRAS—colon cancer	3.65e-05	0.00215	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EGFR—colon cancer	3.64e-05	0.00214	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA7—colon cancer	3.61e-05	0.00213	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VEGFA—colon cancer	3.61e-05	0.00212	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VEGFA—colon cancer	3.58e-05	0.00211	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—NRAS—colon cancer	3.56e-05	0.0021	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—NRAS—colon cancer	3.53e-05	0.00208	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—SRC—colon cancer	3.53e-05	0.00208	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—SRC—colon cancer	3.53e-05	0.00208	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EP300—colon cancer	3.48e-05	0.00205	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—KRAS—colon cancer	3.44e-05	0.00203	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VEGFA—colon cancer	3.44e-05	0.00202	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VEGFA—colon cancer	3.44e-05	0.00202	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—SRC—colon cancer	3.4e-05	0.002	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—SRC—colon cancer	3.4e-05	0.002	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—NRAS—colon cancer	3.4e-05	0.002	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—NRAS—colon cancer	3.4e-05	0.002	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—SRC—colon cancer	3.39e-05	0.00199	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—EGFR—colon cancer	3.37e-05	0.00198	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—HRAS—colon cancer	3.34e-05	0.00197	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VEGFA—colon cancer	3.31e-05	0.00195	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VEGFA—colon cancer	3.31e-05	0.00195	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TGFB1—colon cancer	3.31e-05	0.00195	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VEGFA—colon cancer	3.3e-05	0.00194	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—NRAS—colon cancer	3.27e-05	0.00193	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—NRAS—colon cancer	3.27e-05	0.00193	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—NRAS—colon cancer	3.26e-05	0.00192	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EGFR—colon cancer	3.25e-05	0.00191	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—EGFR—colon cancer	3.22e-05	0.0019	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—KRAS—colon cancer	3.18e-05	0.00187	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	3.17e-05	0.00186	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—EGFR—colon cancer	3.09e-05	0.00182	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—EGFR—colon cancer	3.09e-05	0.00182	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—KRAS—colon cancer	3.07e-05	0.00181	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—KRAS—colon cancer	3.04e-05	0.00179	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CTNNB1—colon cancer	3.03e-05	0.00178	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TGFB1—colon cancer	3.03e-05	0.00178	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—EGFR—colon cancer	2.98e-05	0.00176	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—EGFR—colon cancer	2.98e-05	0.00176	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EGFR—colon cancer	2.97e-05	0.00175	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HRAS—colon cancer	2.93e-05	0.00172	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KRAS—colon cancer	2.92e-05	0.00172	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—KRAS—colon cancer	2.92e-05	0.00172	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CTNNB1—colon cancer	2.9e-05	0.00171	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EP300—colon cancer	2.82e-05	0.00166	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KRAS—colon cancer	2.82e-05	0.00166	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—KRAS—colon cancer	2.82e-05	0.00166	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KRAS—colon cancer	2.81e-05	0.00165	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CTNNB1—colon cancer	2.79e-05	0.00164	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CTNNB1—colon cancer	2.79e-05	0.00164	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	2.77e-05	0.00163	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGFR3—colon cancer	2.75e-05	0.00162	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—SRC—colon cancer	2.74e-05	0.00161	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—colon cancer	2.7e-05	0.00159	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EP300—colon cancer	2.7e-05	0.00159	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—colon cancer	2.69e-05	0.00158	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CTNNB1—colon cancer	2.69e-05	0.00158	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CTNNB1—colon cancer	2.69e-05	0.00158	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PPARG—colon cancer	2.68e-05	0.00158	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—colon cancer	2.67e-05	0.00157	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NRAS—colon cancer	2.64e-05	0.00155	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—SRC—colon cancer	2.62e-05	0.00154	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—colon cancer	2.61e-05	0.00153	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EP300—colon cancer	2.59e-05	0.00152	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EP300—colon cancer	2.59e-05	0.00152	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—colon cancer	2.59e-05	0.00152	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—colon cancer	2.58e-05	0.00152	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	2.56e-05	0.00151	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—colon cancer	2.55e-05	0.0015	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CHST5—colon cancer	2.55e-05	0.0015	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ODC1—colon cancer	2.55e-05	0.0015	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APC—colon cancer	2.53e-05	0.00149	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NRAS—colon cancer	2.53e-05	0.00149	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NRAS—colon cancer	2.52e-05	0.00148	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—SRC—colon cancer	2.52e-05	0.00148	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—SRC—colon cancer	2.52e-05	0.00148	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EP300—colon cancer	2.5e-05	0.00147	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EP300—colon cancer	2.5e-05	0.00147	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—colon cancer	2.48e-05	0.00146	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—colon cancer	2.48e-05	0.00146	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—TGFB1—colon cancer	2.47e-05	0.00145	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—colon cancer	2.45e-05	0.00144	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—colon cancer	2.45e-05	0.00144	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TGFB1—colon cancer	2.45e-05	0.00144	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—SRC—colon cancer	2.43e-05	0.00143	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—SRC—colon cancer	2.43e-05	0.00143	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NRAS—colon cancer	2.42e-05	0.00143	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NRAS—colon cancer	2.42e-05	0.00143	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—colon cancer	2.4e-05	0.00141	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—colon cancer	2.4e-05	0.00141	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—colon cancer	2.4e-05	0.00141	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—SRC—colon cancer	2.39e-05	0.00141	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—colon cancer	2.38e-05	0.0014	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BRAF—colon cancer	2.37e-05	0.0014	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—colon cancer	2.37e-05	0.0014	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—colon cancer	2.37e-05	0.00139	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—colon cancer	2.37e-05	0.00139	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	2.35e-05	0.00138	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TGFB1—colon cancer	2.34e-05	0.00138	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NRAS—colon cancer	2.34e-05	0.00138	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NRAS—colon cancer	2.34e-05	0.00138	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—colon cancer	2.33e-05	0.00137	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—colon cancer	2.3e-05	0.00136	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NRAS—colon cancer	2.3e-05	0.00135	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—colon cancer	2.3e-05	0.00135	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—colon cancer	2.3e-05	0.00135	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—colon cancer	2.27e-05	0.00134	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TGFB1—colon cancer	2.25e-05	0.00133	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TGFB1—colon cancer	2.25e-05	0.00133	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—colon cancer	2.21e-05	0.0013	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—colon cancer	2.21e-05	0.0013	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—PIK3CA—colon cancer	2.2e-05	0.00129	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CHST5—colon cancer	2.19e-05	0.00129	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ODC1—colon cancer	2.19e-05	0.00129	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—colon cancer	2.17e-05	0.00128	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TGFB1—colon cancer	2.17e-05	0.00128	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TGFB1—colon cancer	2.17e-05	0.00128	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—colon cancer	2.17e-05	0.00128	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—colon cancer	2.13e-05	0.00125	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—colon cancer	2.13e-05	0.00125	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—colon cancer	2.11e-05	0.00124	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—colon cancer	2.1e-05	0.00123	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—colon cancer	2.09e-05	0.00123	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—colon cancer	2.09e-05	0.00123	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—colon cancer	2.01e-05	0.00118	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—colon cancer	2.01e-05	0.00118	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PIK3CA—colon cancer	2e-05	0.00118	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—colon cancer	1.98e-05	0.00117	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA7—colon cancer	1.95e-05	0.00115	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—colon cancer	1.93e-05	0.00114	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—colon cancer	1.89e-05	0.00111	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—colon cancer	1.85e-05	0.00109	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—colon cancer	1.84e-05	0.00109	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—colon cancer	1.8e-05	0.00106	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—colon cancer	1.78e-05	0.00105	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—colon cancer	1.77e-05	0.00104	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—colon cancer	1.77e-05	0.00104	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EP300—colon cancer	1.76e-05	0.00103	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—colon cancer	1.73e-05	0.00102	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—colon cancer	1.72e-05	0.00101	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—colon cancer	1.71e-05	0.00101	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—colon cancer	1.71e-05	0.00101	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SRC—colon cancer	1.71e-05	0.001	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—colon cancer	1.7e-05	0.001	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—colon cancer	1.68e-05	0.000991	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1A—colon cancer	1.68e-05	0.000987	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—colon cancer	1.66e-05	0.000979	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—colon cancer	1.64e-05	0.000967	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—colon cancer	1.63e-05	0.00096	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—colon cancer	1.63e-05	0.000959	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EP300—colon cancer	1.6e-05	0.000939	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—colon cancer	1.57e-05	0.000921	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—colon cancer	1.57e-05	0.000921	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SRC—colon cancer	1.55e-05	0.000913	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TGFB1—colon cancer	1.53e-05	0.000898	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—colon cancer	1.51e-05	0.000889	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—colon cancer	1.51e-05	0.000888	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—colon cancer	1.51e-05	0.000888	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—colon cancer	1.5e-05	0.000881	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—colon cancer	1.49e-05	0.000878	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—colon cancer	1.41e-05	0.000832	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—colon cancer	1.39e-05	0.000818	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—colon cancer	1.39e-05	0.000816	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—colon cancer	1.36e-05	0.0008	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—colon cancer	1.28e-05	0.000756	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.24e-05	0.000727	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.23e-05	0.000721	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—colon cancer	1.2e-05	0.000707	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.19e-05	0.000703	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ODC1—colon cancer	1.18e-05	0.000696	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CHST5—colon cancer	1.18e-05	0.000696	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—colon cancer	1.18e-05	0.000694	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—colon cancer	1.14e-05	0.000672	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.1e-05	0.000645	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—colon cancer	1.09e-05	0.000643	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—colon cancer	1.06e-05	0.000624	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—colon cancer	9.64e-06	0.000567	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	9.32e-06	0.000549	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.04e-06	0.000532	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	7.62e-06	0.000448	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.11e-06	0.000419	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—colon cancer	6.73e-06	0.000396	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMS—colon cancer	6.61e-06	0.000389	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EP300—colon cancer	6.5e-06	0.000382	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—colon cancer	6.32e-06	0.000372	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—colon cancer	6.15e-06	0.000362	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—colon cancer	6.08e-06	0.000358	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.91e-06	0.000348	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—colon cancer	5.79e-06	0.000341	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMS—colon cancer	5.68e-06	0.000334	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—colon cancer	5.65e-06	0.000332	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—colon cancer	5.23e-06	0.000308	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—colon cancer	4.81e-06	0.000283	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—colon cancer	4.68e-06	0.000276	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—colon cancer	4.65e-06	0.000274	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—colon cancer	4.45e-06	0.000262	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.37e-06	0.000258	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—colon cancer	4.03e-06	0.000237	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—colon cancer	3.93e-06	0.000231	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—colon cancer	3.68e-06	0.000217	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—colon cancer	3.17e-06	0.000186	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—colon cancer	3.12e-06	0.000184	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMS—colon cancer	3.07e-06	0.000181	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—EP300—colon cancer	3.06e-06	0.00018	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EP300—colon cancer	2.63e-06	0.000155	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—colon cancer	2.27e-06	0.000133	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—colon cancer	2.17e-06	0.000128	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—colon cancer	1.95e-06	0.000115	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—colon cancer	1.85e-06	0.000109	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—colon cancer	1.71e-06	0.000101	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—colon cancer	1.59e-06	9.37e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EP300—colon cancer	1.42e-06	8.37e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—colon cancer	1.05e-06	6.19e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—colon cancer	8.59e-07	5.06e-05	CbGpPWpGaD
